Business Philosophy

Within our niche market, our product line is sufficiently deep to meet the continuing rapid growth needs of our fastest-growing customers.

Our product philosophy is to "go deep, not wide," with all product lines developed in the sequence from "small-scale manual culture to large-scale industrial automated culture."

Within our niche market, our product line is sufficiently broad to provide customers with "turnkey" overall solutions.

In terms of production processes: we cover all aspects of cell culture, cell digestion, cell harvesting, and cell cryopreservation.

Our distinctive philosophy is that "we help our customers make money, not save money."

Most of our customers are corporate clients, whom we believe are vastly different from individual consumers. The products or solutions we provide to customers enable them to develop their own products in a shorter time, thereby generating sales. Rather than saving money on product procurement but delaying product launch and losing potential sales revenue, our design is not based on how to reduce costs but on "how to design products to increase output."

Our company has strong financial prowess, significantly reducing supply chain risks for our customers.

Yocon possesses a fully owned research and development (R&D) and production base located in Miyun District, Beijing. With a total investment of 250 million yuan and a construction area of 42,000 square meters, the base was constructed in 2021 and officially commenced production in May 2024. Designed and built to comply with the regulatory requirements of China, the United States, and the European Union simultaneously, the base boasts hardware conditions comparable to international peers. Our products meet the requirements of multiple national regulatory bodies and have undergone testing by reputable third-party testing institutions within the industry. Notably, our MSC serum-free medium is the second product globally to obtain the US FDA's 510K Class II medical device registration certificate.

Yocon is one of the few enterprises in China that uses "injection-grade distilled water" for the production of liquid media.

This enables us to meet the statutory requirements of the National Medical Products Administration (NMPA) for cell preparations or exosome preparations intended for human use.